Stämm's Continuous Bioreactor Increases Antibody Productivity by up to 30x in European and American Pilots
Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability using Stämm's bubble-free continuous laminar flow bioreactor: the Bioprocessor. SAN FRANCISCO, Jan....